triamcinolone acetonide has been researched along with Polyps in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, N; Kubota, M; Sakai, T; Tsuneoka, H | 1 |
| Iida, T; Itagaki, K; Kano, M; Saito, M | 1 |
| Hayashi, T; Kohno, H; Ohkuma, Y; Sakai, T; Tsuneoka, H; Watanabe, A | 1 |
| Hsiao, TY; Lai, MS; Wang, CT | 1 |
| Akagi-Kurashige, Y; Iwama, D; Nakata, I; Ooto, S; Otani, A; Tsujikawa, A; Ueda-Arakawa, N; Yamashiro, K; Yoshimura, N | 1 |
2 trial(s) available for triamcinolone acetonide and Polyps
| Article | Year |
|---|---|
Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid Diseases; Drug Resistance; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Pigment Epithelium; Retrospective Studies; Tenon Capsule; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2017 |
Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
3 other study(ies) available for triamcinolone acetonide and Polyps
| Article | Year |
|---|---|
Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2014 |
Comprehensive Outcome Researches of Intralesional Steroid Injection on Benign Vocal Fold Lesions.
Topics: Acoustics; Adolescent; Adult; Aged; Cysts; Dexamethasone; Dilatation, Pathologic; Disability Evaluation; Female; Glucocorticoids; Humans; Injections, Intralesional; Laryngeal Diseases; Laryngoscopy; Male; Middle Aged; Polyps; Prospective Studies; Recovery of Function; Speech Production Measurement; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Vocal Cords; Voice Disorders; Voice Quality; Young Adult | 2015 |
Two-year outcome of photodynamic therapy combined with intravitreal injection of bevacizumab and triamcinolone acetonide for polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroid Diseases; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Male; Photochemotherapy; Polyps; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Hemorrhage | 2013 |